Dr. Naira Baregamian

Surgical Oncology | General Surgery
3601 The Vanderbilt Clinic, 
Nashville, TN 
Accepting New Patients
Offers Telehealth
3601 The Vanderbilt Clinic, 
Nashville, TN 
OverviewInsuranceLocationsClinical Research

Overview

Naira Baregamian is a Surgical Oncologist and a General Surgeon in Nashville, Tennessee. Dr. Baregamian is rated as an Experienced provider by MediFind in the treatment of Familial Hyperthyroidism due to Mutations in TSH Receptor. Her top areas of expertise are Hyperparathyroidism, Parathyroid Hyperplasia, Familial Isolated Hyperparathyroidism, Parathyroidectomy, and Thyroidectomy. Dr. Baregamian is currently accepting new patients.

Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Surgical Oncology
General Surgery
Licenses
Surgery in TN
Languages Spoken
English
Armenian
Russian
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

3601 The Vanderbilt Clinic, Nashville, TN 37232
Other Locations
1215 21st Ave S, Medical Center East South Tower 8210, Nashville, TN 37232

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy.
Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy.
Enrollment Status: Completed
Publish Date: October 17, 2024
Intervention Type: Device
Study Phase: Not Applicable
Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
Enrollment Status: Completed
Publish Date: May 13, 2024
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

35 Total Publications

An integrated single-cell and spatial transcriptomic atlas of thyroid cancer progression identifies prognostic fibroblast subpopulations.
An integrated single-cell and spatial transcriptomic atlas of thyroid cancer progression identifies prognostic fibroblast subpopulations.
Journal: JCI insight
Published: February 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Baregamian's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile